M&A Advisory Series
Understanding Federal Taxes
in an Asset Deal
Asset deals are the most common transaction structure in healthcare M&A. Understanding the federal tax implications for both buyer and seller is essential to maximizing your after-tax proceeds and structuring a deal that works for all parties.
How Asset Deals Work in Healthcare M&A
In an asset deal, the buyer acquires specific assets and assumed liabilities of the business — not the legal entity itself. This is the standard structure in healthcare M&A, and it creates tax consequences for both sides that are directly shaped by how the purchase price is allocated across asset classes under IRC §1060.
- Full step-up in tax basis on acquired assets
- §197 amortization of goodwill over 15 years
- No inherited liabilities, audits, or contingent claims
- Clean break from seller's legal entity and history
- S-Corp pass-through avoids double taxation
- Goodwill allocation creates favorable LTCG treatment
- F-Reorganization defers rollover equity tax to exit
- Asset deals are market standard — few PE buyers do stock deals
The Good News: Most of Your Deal Is Taxed at Capital Gains Rates
For the typical healthcare practice owner selling through an S-Corporation, the large majority of the purchase price is allocated to goodwill — the value of your patient relationships, reputation, and workforce. Goodwill held more than 12 months is taxed at long-term capital gains (LTCG) rates, not ordinary income rates. This is one of the most favorable aspects of a healthcare M&A transaction.
Why LTCG Treatment Is So Valuable: Ordinary income — wages, non-compete payments, accounts receivable — is taxed federally at rates up to 37%. Long-term capital gains are taxed at a maximum federal rate of just 20%. On a $3M practice sale where 85% of value is goodwill, the seller's blended effective federal rate can be well under 25%, even accounting for the ordinary income wedge created by A/R, equipment recapture, and non-competes. The spread between ordinary income and LTCG rates represents tens of thousands of dollars in tax savings per million of deal value — making purchase price allocation one of the highest-leverage tax planning decisions in your transaction.
(Goodwill)
(A/R, Non-Compete)
of Goodwill vs. OI
Federal Purchase Price Allocation — The 7-Class Framework
Under IRC §1060, both buyer and seller must allocate the purchase price among assets using the IRS's residual method across seven asset classes. Each class carries different tax treatment. The allocation is reported on IRS Form 8594 and must be consistent between buyer and seller.
| Asset Class | Examples | Seller Tax Treatment | Buyer Benefit |
|---|---|---|---|
| Class I — Cash & Cash Equivalents | Bank accounts, foreign currency | No gain/loss (basis = FMV) | None |
| Class II — Securities | Actively traded personal property | Capital gain/loss | Step-up to FMV |
| Class III — MTM Assets | A/R, inventory (FIFO) | Ordinary Income up to 37% | Immediate deduction on use/sale |
| Class IV — Inventory | Stock in trade, goods held for sale | Ordinary Income up to 37% | COGS deduction on sale |
| Class V — Fixed Assets | Equipment, furniture, vehicles, real estate | §1245/ |
Depreciation step-up; bonus depreciation may apply |
| Class VI — §197 Intangibles | Non-competes, workforce in place, licenses | Ordinary Income (non-competes = OI; others vary) | 15-year amortization under §197 |
| Class VII — Goodwill & Going Concern | Enterprise goodwill, customer relationships | Capital Gain ≤ 23.8% (incl. NIIT) | 15-year amortization under §197 |
Strategic Insight: Sellers benefit most from maximizing goodwill (Class VII) allocation due to lower long-term capital gains rates. Buyers benefit most from Classes V and VI, which generate faster and larger deductions. This natural tension over allocation is one of the most consequential negotiating points in any transaction. Mihama helps clients navigate these competing interests to reach a tax-efficient structure for all parties.
The Average Mihama Deal: Structure, Timeline & Federal Tax Outcome
Every deal is different, but Mihama has observed consistent patterns across hundreds of healthcare M&A transactions. Understanding what a typical deal looks like — structurally and tax-wise — helps sellers set realistic expectations and plan appropriately before they ever sign a letter of intent.
At Closing: ~56% of Deal Value in Cash
Of the 70% cash portion, 20% is held in escrow. The seller receives ~56% of total deal value at closing (70% × 80%). On a $3M deal, that is ~$1.68M wired on day one. The remaining $420K sits in escrow pending reps and warranties satisfaction — standard in PE-backed transactions.
12–24 Months Post-Close: Escrow Released
Assuming no material claims (the typical outcome), the escrow releases to the seller 12–24 months after closing. This $420K is taxable in the year received under IRC §453, allowing the seller to defer a portion of the tax to that year. Coordinate escrow release timing with your CPA for optimal planning.
The Rollover: 30% Deferred via F-Reorganization
The 30% rollover is contributed into the buyer's partnership via a §721 exchange under an F-Reorganization. No tax is owed on the rollover at closing. The seller receives equity units at entry valuation; this stake appreciates over the 4–7 year hold period before a second-event sale triggers recognition of the deferred gain plus any additional appreciation.
Second-Event Sale: Rollover Gain Recognized
When the platform sells, the seller recognizes gain on their equity stake — both the original deferred amount and appreciation since entry. If held >12 months (almost always), the gain is taxed at LTCG rates. Sellers who rolled into a growing platform often find second-event proceeds rival or exceed the original deal value.
For a materially participating S-Corporation owner in the top federal bracket, the blended effective federal rate on the cash portions of an average deal typically falls in the 21–24% range. Here is why it lands there:
- A/R is fully ordinary income (37%) for cash-basis S-Corps
- Depreciation recapture on equipment taxed as ordinary income (37%)
- Non-compete payments always ordinary income (37%)
- These ordinary income items blended in push the effective rate above the 20% LTCG floor
- Goodwill (85%+ of most deals) taxed at 20% LTCG
- No NIIT (3.8%) for materially participating owners
- S-Corp pass-through avoids 21% corporate-level tax
- No double taxation on proceeds distributed to the owner
Bottom Line: A materially participating S-Corp owner selling a well-structured practice through Mihama should expect to keep roughly 76–79 cents of every federal dollar on the cash portions of their deal — before state taxes. The rollover portion is tax-deferred entirely until the second-event exit, at which point additional appreciation is also recognized. State and local taxes, which vary widely by jurisdiction, will reduce the net proceeds further and must be modeled separately with a qualified CPA.
Key Federal Tax Events for a Selling Entity
Depreciation Recapture (§1245 / §1250)
Prior depreciation on tangible personal property (§1245) is recaptured as ordinary income. Real property (§1250) recapture — known as "unrecaptured §1250 gain" — is taxed at a maximum 25% federal rate.
Ordinary Income on Working Capital Assets
Gains on A/R, inventory, and non-compete payments flow through as ordinary income taxed at rates up to 37% for individuals, or 21% for C-Corporations.
Long-Term Capital Gain on Goodwill
Assets held >12 months qualify for LTCG rates of 0%, 15%, or 20% depending on taxable income. Most healthcare practice owners fall in the 20% bracket on goodwill.
Net Investment Income Tax (NIIT) — Not Applicable to Materially Participating Owners
The 3.8% NIIT under IRC §1411 applies to net investment income for individuals with MAGI above $200K (single) / $250K (MFJ). However, the NIIT does not apply where the taxpayer materially participates in the business (IRC §469). For the active practice owner, goodwill gain is exempt — effective LTCG rate is 20%, not 23.8%. On a $2.5M goodwill gain, this saves ~$95,000 versus a passive investor. Confirm your material participation status with your CPA.
How the Seller's Entity Type Changes the Federal Tax Picture
The tax outcome of an asset deal varies significantly depending on whether the seller is a C-Corporation, S-Corporation, or Partnership/LLC. The most common structure seen in healthcare M&A involves pass-through entities.
| Entity Type | Federal Tax at Entity Level | Federal Tax at Owner Level | Key Risk / Consideration |
|---|---|---|---|
| C-Corporation | 21% corporate tax on all gains (ordinary & capital) | Dividend tax on remaining proceeds (0–23.8%) | Double taxation makes asset deals particularly punitive for C-Corps |
| S-Corporation | No entity-level tax (pass-through); LIFO recapture may apply | Gains passed to shareholders per ownership %; taxed at individual rates | Built-in Gains Tax (§1374) may apply if S-Corp was previously a C-Corp within 5 years |
| Partnership / LLC | No entity-level tax; §751 "hot assets" (A/R, inventory) produce ordinary income | Allocated gains taxed at individual rates; basis adjustments under §754 apply | §751 ordinary income taint must be analyzed on all asset sales |
| Sole Proprietor | No separate entity; Schedule C income and self-employment considerations apply | All gains taxed directly at individual rates; SE tax may apply to ordinary gains | Simpler structure but all recapture flows directly to owner's return |
How Rollover Equity is Taxed — and How the F-Reorganization Changes Everything
In many healthcare M&A transactions, the buyer asks the seller to "roll over" a portion of their equity — retaining a minority ownership stake in the acquiring platform rather than receiving full cash at close. How the rollover is taxed depends entirely on how the transaction is structured.
The seller recognizes gain on all assets sold — including the portion attributable to the rollover equity stake — in the year of closing. There is no deferral. The rollover is treated as if the seller received fair market value in cash and immediately reinvested it. Tax is owed at closing on proceeds the seller has not yet received in cash, creating a liquidity problem.
The rollover portion is treated as a continuation of the seller's ownership — not a taxable sale. Tax on the rollover is fully deferred until the seller exits the platform at the second-event sale. Only the cash portion of the deal is taxed at closing. The seller takes a carryover basis in the new platform equity, and the deferred gain is recognized when that stake is eventually sold.
Under IRC §368(a)(1)(F), an F-Reorganization is defined as a "mere change in identity, form, or place of organization of one corporation." In practice, private equity buyers use it as a pre-transaction restructuring step — typically converting the target S-Corporation into an LLC taxed as a partnership prior to closing. The key steps are:
Seller Forms a New Holding Company (Newco)
The seller contributes their S-Corp stock into a newly formed holding company. This is a non-taxable event — treated as an F-Reorganization under federal law. The IRS views Newco as the mere continuation of the original entity.
Target S-Corp Converts to an LLC
The target S-Corp is converted into a single-member LLC (a disregarded entity) under state law. Newco now owns the LLC. This conversion is also non-taxable and typically occurs at least one day after the F-Reorg steps.
Buyer Acquires a Percentage of the LLC from Newco
The buyer (typically a PE-backed LLC taxed as a partnership) purchases the cash portion of the deal by acquiring the seller's interest in the LLC directly. For tax purposes, this is treated as an asset acquisition with a full basis step-up on the purchased percentage — giving the buyer the same economic result as a pure asset deal.
Seller Contributes Rollover Stake into Buyer's Entity (§721 Exchange)
The rollover portion is contributed by Newco into the buyer's partnership/LLC in exchange for equity units. Under IRC §721, contributions to a partnership in exchange for a partnership interest are generally non-taxable. The seller's deferred gain carries over into the new platform equity and is only recognized at exit.
Why PE Buyers Run F-Reorgs: The F-Reorg is the predominant deal structure used by private equity buyers in healthcare M&A for several reasons: it gives the buyer a full asset basis step-up on the purchased portion (same as a pure asset deal), it allows the seller to defer taxes on the rollover equity until exit, it avoids the 80% purchase threshold required by a §338(h)(10) election, it sidesteps contract assignment and consent issues common in pure asset deals, and it allows the buyer to retain the target's EIN — simplifying operational continuity. The seller benefits from tax deferral on the rollover; the buyer benefits from the step-up. It is broadly considered the most tax-efficient structure when a rollover is involved.
Important Caveats: The F-Reorg only applies when the target is an S-Corporation (the most common structure in PT practices). Anti-churning rules under §197(f) must be analyzed — if the seller owns more than 20% of the buyer post-close and the business predates 1993, amortization of the goodwill step-up may be restricted. State conformity varies. And because the rollover gain is merely deferred — not eliminated — the seller will owe tax on the full accumulated gain (original deferred gain plus any additional appreciation) when the platform ultimately sells. This analysis requires a qualified tax attorney and CPA working in coordination.
Earnouts & Seller Notes — IRC §453
When a portion of the purchase price is paid via an earnout or seller note, the seller may elect installment sale treatment, deferring gain recognition to the tax years in which payments are received.
- Gain is recognized proportionally as payments are received
- Ordinary income items (A/R, recapture) cannot be deferred — recognized in year of sale
- Sellers may "opt out" of installment treatment if beneficial (e.g., capital losses to offset)
- Interest on deferred payments is ordinary income to the seller
Negotiating the Purchase Price Allocation
Both buyer and seller must file Form 8594 and use consistent allocations. While the allocation must reflect economic reality, there is often room to negotiate within defensible ranges.
- Sellers prefer: Maximum to goodwill (LTCG); minimum to ordinary income items
- Buyers prefer: More to short-life assets (faster deductions); less to 15-year goodwill
- Non-compete values must be defensible under the "with-and-without" methodology
- Mismatched allocations trigger IRS scrutiny — consistency is required
S-Corporation Asset Sale: Materially Participating Owner
The following is a simplified illustrative example of how federal taxes may apply to a single owner of a physical therapy S-Corporation who is materially involved in day-to-day operations. Actual results depend on individual circumstances; consult a qualified tax advisor.
| Gross Purchase Price | $3,000,000 |
| Entity Type | S-Corporation |
| Ownership | 100% — Single Owner |
| Owner's Basis in S-Corp Stock | $150,000 |
| Owner's Tax Filing Status | Married Filing Jointly |
| Accounts Receivable (Class III) | $150,000 |
| Equipment & Tangible Assets (Class V) | $200,000 |
| Non-Compete Agreement (Class VI) | $75,000 |
| Goodwill (Class VII) | $2,575,000 |
| Total | $3,000,000 |
A Note on Non-Compete Valuation: Non-compete allocations must reflect economic reality and withstand IRS scrutiny under the "with-and-without" methodology. For a physical therapy practice, the non-compete typically represents a modest portion of total purchase price — often $50,000–$150,000 — based on the realistic probability that the selling owner could meaningfully compete post-sale, the geographic scope and duration of the covenant, and the owner's patient relationships. An allocation far in excess of this range risks IRS challenge. The $75,000 used here reflects a defensible market-rate allocation for a 3-year, regional covenant.
Accounts Receivable Included in Enterprise Value: In most healthcare M&A transactions, the buyer acquires A/R as part of the deal. The $150,000 A/R here represents outstanding billings at close. Because A/R carries a basis approximately equal to face value for a cash-basis S-Corporation, the tax impact is the full face amount recognized as ordinary income in the year of sale. Sellers should confirm their A/R basis with their CPA prior to negotiations.
| Asset / Income Category | Gain Recognized | Character | Federal Rate | Est. Tax |
|---|---|---|---|---|
| Accounts Receivable (Cash-basis S-Corp; zero tax basis in A/R) |
$150,000 | Ordinary Income | 37% | $55,500 |
| §1245 Depreciation Recapture — Equipment (FMV $200K; adjusted basis $80K; accumulated depreciation $120K) |
$120,000 | Ordinary Income | 37% | $44,400 |
| Remaining Equipment Gain (FMV $200K − adjusted basis $80K = $120K total gain; fully recaptured above) |
$0 | Capital Gain | 20% | $0 |
| Non-Compete Agreement (Full amount — zero basis; always ordinary income regardless of how paid) |
$75,000 | Ordinary Income | 37% | $27,750 |
| Goodwill (Held >12 months; LTCG treatment applies. Material participation → no NIIT on this gain) |
$2,575,000 | Long-Term Cap. Gain | 20% | $515,000 |
| Estimated Total Federal Tax Liability | Effective Rate: 21.4% | $642,650 | ||
| Estimated After-Tax Proceeds (Federal only; state taxes additional) | $2,357,350 | |||
Building on the $3,000,000 transaction above, assume the PE buyer runs an F-Reorganization and structures the deal as 70% cash at close with 30% retained as rollover equity in the acquiring platform. Of the 70% cash portion, 20% is held in escrow. Under the F-Reorg, the rollover equity gain is deferred — not taxed at closing — which is the primary reason PE buyers use this structure when a rollover is involved.
| Proceeds Component | Amount | When Tax is Owed | Pro-Rata Federal Tax* |
|---|---|---|---|
| Cash at Close | $1,680,000 | Year of closing — tax due by April 15 (or estimated quarterly) | ~$360,284 |
| Escrow Release | $420,000 | Year escrow is released — deferred 12–24 months | ~$90,051 |
| Rollover Equity (30% of deal — F-Reorg + §721) Contribution to buyer partnership; gain deferred under §721 |
$900,000 | DEFERRED — Owed at Exit No tax at closing; recognized at second-event sale |
$0 now |
| Total Federal Tax Due at / Near Closing (F-Reorg) | ~$192K in rollover tax deferred to exit vs. pure asset deal | $450,335 | |
| Estimated After-Tax Cash at / Near Closing (Federal only; rollover tax deferred to exit) | $1,649,665 | ||
| Rollover tax deferred — owed at future platform exit on accumulated gain at that time | ~$192K+ TBD | ||
📌 Simplification Note on Rollover Equity Valuation: For purposes of this example, the rollover equity is valued at entry — meaning the $900,000 represents 30% of the original $3,000,000 purchase price and becomes the seller's carryover tax basis in the platform equity under the F-Reorg. In practice, the actual value of the rollover stake at a future exit will be determined by the platform's EBITDA performance at the time of sale multiplied by the applicable exit multiple — which may be meaningfully higher than the entry multiple if the platform grows. The $900,000 is the deferred gain basis, not a guaranteed exit value. The full deferred tax (plus any additional gain on appreciation) will be owed at the second-event sale.
The F-Reorg Advantage — Solving the Rollover Tax Liquidity Problem: In a pure asset deal without an F-Reorg, the seller would owe approximately $192,315 in federal tax on the rollover equity at closing — on proceeds never received in cash. The F-Reorg eliminates this problem by deferring that gain to the exit event. Under the F-Reorg structure shown here, only $450,335 in federal tax is due at or near closing (cash proceeds only), compared to $642,650 in a pure asset deal — a near-term federal tax saving of approximately $192,315. That deferred tax will ultimately be owed when the platform sells, likely at long-term capital gains rates, and on whatever the rollover stake has grown to at that point. This is why the F-Reorg is the preferred structure for PE buyers when a rollover is part of the deal. *Pro-rata tax estimates are allocated proportionally to total gain; actual allocation depends on asset-by-asset character analysis.
Key Takeaways for the Materially Participating S-Corp Owner: The blended effective federal rate in this example is 21.4% on total proceeds — a meaningful advantage versus a C-Corporation seller who would face double taxation. Because the owner is materially participating in the business, the goodwill gain avoids the 3.8% Net Investment Income Tax (NIIT), saving an additional ~$97,850 compared to a passive investor. The two largest tax drivers are goodwill (the single biggest item, taxed favorably at 20%) and the ordinary income "wedge" created by A/R, depreciation recapture, and the non-compete, which collectively generate ~$127,650 in tax at 37%. State and local taxes are additive and will meaningfully increase the total tax burden depending on jurisdiction.
State & Local Tax: An Important Reminder
This guide focuses exclusively on federal tax treatment. State and local income taxes on M&A transactions vary significantly by jurisdiction and depend on each individual's and entity's specific circumstances, including the seller's state of domicile, where business is conducted, nexus considerations, and each state's conformity (or lack thereof) to federal tax law. Sellers operating across multiple states may face apportionment and sourcing issues that add further complexity. Each transaction requires individualized state tax analysis by a qualified tax professional.
What Does All of This Mean in Simple Terms?
Think of your sale price as being split into buckets — equipment, goodwill, your non-compete, and so on. The IRS taxes each bucket differently. The big one — goodwill, which is essentially the value of your business's reputation and patient relationships — gets the best tax treatment at just 20%. Other buckets, like money owed to you (A/R) or your non-compete payment, get taxed at your regular income rate of up to 37%.
If you own an S-Corporation (the most common setup for PT practices), your business doesn't pay tax — you do, personally, on your tax return. This is actually a good thing. A C-Corporation would get hit with a 21% corporate tax first, and then you'd pay tax again when you take the money out. The S-Corp structure avoids that double-taxation.
You and the buyer have to agree on how the total price is divided among the different assets. This is called the "allocation." More money allocated to goodwill is better for you as the seller (lower taxes). More money to equipment or non-competes is better for the buyer (bigger deductions). Getting this right is one of the most valuable things your M&A advisor and CPA can do for you.
If part of your cash deal is held in escrow (which is standard), you generally don't pay tax on that money until it is released to you down the road. Furthermore, if your deal includes "rollover equity" — keeping a stake in the new company — Mihama will negotiate for the buyer to use a structure called an F-Reorganization. This allows you to defer the taxes on your rollover stake until you eventually sell it, saving you from paying taxes on money you haven't received yet.
📌 A Note on Escrow and "Front-Loaded" Taxes: Under IRS installment sale rules (IRC §453), certain ordinary income items — such as depreciation recapture and accounts receivable — cannot be deferred and must be fully recognized in the year of the sale, even if a portion of your cash is tied up in escrow. As a result, your actual tax payment due at closing will likely be slightly "front-loaded" (higher than a straight pro-rata estimate), while the tax due upon your future escrow release will be lower, consisting almost entirely of long-term capital gains.
Everything above is just the federal side of your tax bill. Every state is different — some states have no income tax, others have rates close to 10% or higher. Your total tax burden (federal + state) could be meaningfully higher than the federal-only numbers shown in this guide. This is why it's essential to work with a CPA who understands your specific state tax situation well before you sign any deal documents.